[HTML][HTML] Necroptosis in the pathophysiology of disease

MK Khoury, K Gupta, SR Franco, B Liu - The American journal of pathology, 2020 - Elsevier
Over the past 15 years, elegant studies have demonstrated that in certain conditions,
programed cell death resembles necrosis and depends on a unique molecular pathway with …

[HTML][HTML] Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease

WY Wang, MS Tan, JT Yu, L Tan - Annals of translational medicine, 2015 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the brain, which is
characterized by the formation of extracellular amyloid plaques (or senile plaques) and …

Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions

A Abeysinghe, R Deshapriya, C Udawatte - Life sciences, 2020 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder and is identified as the most
common cause for dementia. Despite huge global economic burden and the impact on the …

Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease

BS Thawkar, G Kaur - Journal of neuroimmunology, 2019 - Elsevier
Microglial activation is a distinguished attribute in many neurodegenerative diseases of
aging. Compelling evidence suggests that neuroinflammation stimulated by microglia, the …

[HTML][HTML] Stigmasterol attenuates inflammatory response of microglia via NF-κB and NLRP3 signaling by AMPK activation

F Jie, X Yang, B Yang, Y Liu, L Wu, B Lu - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia in the elderly. Although its
pathogenesis remains unclear, studies have indicated microglia-mediated …

Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis

CC Tan, JT Yu, HF Wang, MS Tan… - Journal of …, 2014 - content.iospress.com
Background: The role of currently available drugs for Alzheimer's disease (AD) has been
controversial, with some national formularies restricting their use, and health economists …

Physical activity can improve cognition in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials

Z Du, Y Li, J Li, C Zhou, F Li, X Yang - Clinical interventions in …, 2018 - Taylor & Francis
Background/objective Alzheimer's disease (AD) is mainly characterized by decline of
cognitive functions such as memory and learning, which has a high prevalence and poor …

The role of endoplasmic reticulum stress in neurodegenerative disease

C Xiang, Y Wang, H Zhang, F Han - Apoptosis, 2017 - Springer
The endoplasmic reticulum (ER) is an important organelle involved in cellular homeostasis
and control of protein quality. Unfolded protein response (UPR) is a cellular response to ER …

Necroptosis in neurodegenerative diseases: a potential therapeutic target

S Zhang, M Tang, H Luo, C Shi, Y Xu - Cell death & disease, 2017 - nature.com
Neurodegenerative diseases are a group of chronic progressive disorders characterized by
neuronal loss. Necroptosis, a recently discovered form of programmed cell death, is a cell …

[HTML][HTML] Rate of early onset Alzheimer's disease: a systematic review and meta-analysis

XC Zhu, L Tan, HF Wang, T Jiang, L Cao… - Annals of …, 2015 - ncbi.nlm.nih.gov
It is generally accepted that the population rate of early onset Alzheimer's disease (EOAD) in
Alzheimer's disease (AD) is 1-2%. However, the true population based rate of EOAD has …